THE KINGDOM OF LESOTHO COMBINED SECOND TO EIGHTH PERIODIC REPORT UNDER THE AFRICAN
CHARTER ON HUMAN AND PEOPLES’ RIGHTS AND INITIAL REPORT UNDER THE PROTOCOL TO THE
AFRICAN CHARTER ON THE RIGHTS OF WOMEN IN AFRICA
Table A13: Situation vaccination, deworming and Vitamin A supplementation coverage
in children under five years by Districts, July 2017
District
Vitamin A
Deworming
Measles
DPT 3
Rubella
Buthat-Buthe
69.8%
57.3%
85.4%
91.7%
Leribe
70.1%
63.1%
82.8%
86.6%
Berea
80.3%
65.0%
96.4%
79.6%
Maseru
82.5%
70.2%
85.5%
79.8%
Mafeteng
84.7%
72.9%
96.9%
88.1%
Mohale’s Hoek
86.0%
84.1%
86.9%
91.6%
Quthing
92.9%
84.3%
85.7%
90.0%
Qacha’s Nek
90.7%
88.4%
97.7%
100.0%
Mokhotlong
44.4%
20.0%
73.3%
80.0%
Thaba-Tseka
80.6%
59.7%
86.1%
90.3%
Source: Lesotho Vulnerability Assessment Committee Report, July 2017.
HIV/AIDS
178. HIV/ AIDS is a burden to the health sector and is one of the factors that have contributed
to the slow economic growth and social progress in Lesotho. AIDS has become the
leading cause of morbidity and mortality in Lesotho. Lesotho has HIV prevalence rate of
twenty-five per cent of adults aged 15-49 years old and is one of the highest prevalence
rates in the world. Women are most hit by this pandemic (HIV prevalence indicators and
their effect on women are illustrated in part B of this report).
179. In order to mitigate this challenge, in June 2016, Lesotho became the first African country
to implement a ‘Test and Treat’ strategy. The Strategy was launched on 19 April 2016.
78